Cognitive Decline in Pituitary Tumor Patients Linked to Hormones and Gut Health Patients with pituitary neuroendocrine tumors (PitNETs) often experience cognitive deficits—particularly in attention, executive function, and memory—that significantly impact …
Tag:
HORMONE
-
-
AI Predicts Drug Effectiveness with Unprecedented Accuracy A new artificial intelligence model developed by researchers at the Korea Advanced Institute of Science and Technology (KAIST) is poised to significantly accelerate …
-
Han Hye-yeon’s Weight Loss and Body Maintenance Secrets Stylist and broadcaster Han Hye-yeon has revealed her strategies for maintaining a healthy weight and physique, successfully losing 16kg and currently maintaining …
-
Lettuce-Delivered GLP-1s: A Potential Game Changer for Diabetes and Obesity Treatment Glucagon-like peptide-1 (GLP-1) receptor agonists have rapidly become a focal point in the treatment of both type 2 diabetes …
-
Vaginal Estrogen Therapy Safe for Young Endometrial Cancer Survivors, Study Finds Despite a rising incidence of endometrial cancer in younger women, research has been limited regarding the safety of local, …
-
UCF Researcher Pioneers New Therapy for Diabetic Neuropathy Neuropathy—chronic pain, numbness, and tingling in the hands and feet—significantly impacts many individuals with Type 1 diabetes. Now, a researcher at the …
-
Blocking Growth Hormone Receptor Shows Promise in Combating Treatment-Resistant Lung Cancer Lung cancer remains the leading cause of cancer-related deaths globally, but a new study from Ohio University suggests a …
-
AI Accurately Diagnoses Rare Hormone Disorder from Hand Images A new artificial intelligence (AI) system developed by researchers at Kobe University can accurately diagnose acromegaly, a rare and often delayed-diagnosis …
-
The Yo-Yo Effect of GLP-1 Medications: Managing Weight Regain After Discontinuation The rising popularity of GLP-1 receptor agonist medications like Wegovy and Mounjaro for weight loss is accompanied by a …
-
Technology
Dapiglutide Trial: Dual Gut Hormone Agonist Shows Promise But Fails to Beat Placebo for Obesity
Dapiglutide: Novel GLP-1/GLP-2 Agonist Shows Promise in Early Obesity Trials A new drug, dapiglutide, combining GLP-1 and GLP-2 receptor activation, is being investigated as a potential treatment for obesity. Early …